DS

David Satijn

GA Genmab A/S: 4 patents #3 of 27Top 15%
HA H. Lundbeck A/S: 4 patents #7 of 63Top 15%
BS Biontech Se: 1 patents #1 of 5Top 20%
📍 Utrecht, NL: #4 of 167 inventorsTop 3%
Overall (2019): #14,748 of 560,194Top 3%
8
Patents 2019

Issued Patents 2019

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDate
10512688 Antibodies binding AXL Esther BREIJ, Edward Norbert Van Den Brink, Dennis VERZIJL, Rob N. De Jong, Paul Parren +1 more 2019-12-24
10500276 Antibodies binding AXL Esther BREIJ, Edward Norbert Van Den Brink, Dennis VERZIJL, Rob N. De Jong, Paul Parren +1 more 2019-12-10
10457735 Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domains Ugur Sahin, Friederike Gieseke, Isil Altintas, Paul Parren 2019-10-29
10364285 Antibodies for the treatment of synucleinopathy Pekka Kallunki, Karina Fog, Louise Buur Vesterager, Ann-Louise Bergstrôm, Florence Sotty +6 more 2019-07-30
10358484 Antibodies for the treatment of synucleinopathy Pekka Kallunki, Karina Fog, Louise Buur Vesterager, Ann-Louise Bergstrôm, Florence Sotty +6 more 2019-07-23
10358483 Antibodies for the treatment of synucleinopathy Pekka Kallunki, Karina Fog, Louise Buur Vesterager, Ann-Louise Bergstrôm, Florence Sotty +6 more 2019-07-23
10358482 Antibodies for the treatment of synucleinopathy Pekka Kallunki, Karina Fog, Louise Buur Vesterager, Ann-Louise Bergstrôm, Florence Sotty +6 more 2019-07-23
10201607 Antibodies binding AXL Esther BREIJ, Edward Norbert Van Den Brink, Dennis VERZIJL, Rob N. De Jong, Paul Parren +1 more 2019-02-12